These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9663361

  • 1. Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group.
    Rusk C, Sharpe E, Laurence J, Polis A, Adamsons I.
    Clin Ther; 1998; 20(3):454-66. PubMed ID: 9663361
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
    Boyle JE, Ghosh K, Gieser DK, Adamsons IA.
    Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE, Ghosh K, Gieser DK, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [Abstract] [Full Text] [Related]

  • 4. A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study.
    Simpson AJ, Gray TB, Ballantyne C.
    Aust N Z J Ophthalmol; 1996 Feb; 24(1):39-42. PubMed ID: 8743003
    [Abstract] [Full Text] [Related]

  • 5. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.
    Strahlman E, Tipping R, Vogel R.
    Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651
    [Abstract] [Full Text] [Related]

  • 6. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.
    Wilkerson M, Cyrlin M, Lippa EA, Esposito D, Deasy D, Panebianco D, Fazio R, Yablonski M, Shields MB.
    Arch Ophthalmol; 1993 Oct; 111(10):1343-50. PubMed ID: 8216014
    [Abstract] [Full Text] [Related]

  • 7. The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Sall K.
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S155-62. PubMed ID: 10665518
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of dorzolamide, a topical carbonic anhydrase inhibitor, in combination with timolol in the treatment of patients with open-angle glaucoma and ocular hypertension.
    Hartenbaum D.
    Clin Ther; 1996 Jan; 18(3):460-5. PubMed ID: 8829021
    [Abstract] [Full Text] [Related]

  • 9. Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension.
    Hartenbaum D, Maloney S, Vaccarelli L, Liss C, Wilson H, Gormley GJ.
    Clin Ther; 1999 Sep; 21(9):1533-8. PubMed ID: 10509848
    [Abstract] [Full Text] [Related]

  • 10. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE, Friren B, International Brinzolamide Adjunctive Study Group.
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1998 Oct; 105(10):1936-44. PubMed ID: 9787367
    [Abstract] [Full Text] [Related]

  • 12. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.
    Simmons ST, Alphagan/Trusopt Study Group.
    Clin Ther; 2001 Apr; 23(4):604-19. PubMed ID: 11354394
    [Abstract] [Full Text] [Related]

  • 14. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
    Strahlman ER, Vogel R, Tipping R, Clineschmidt CM.
    Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
    Heijl A, Strahlman E, Sverrisson T, Brinchman-Hansen O, Puustjärvi T, Tipping R.
    Ophthalmology; 1997 Jan; 104(1):137-42. PubMed ID: 9022118
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009 Jan; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I, Clineschmidt C, Polis A, Taylor J, Shedden A, Laibovitz R.
    J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783
    [Abstract] [Full Text] [Related]

  • 20. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.
    Balfour JA, Wilde MI.
    Drugs Aging; 1997 May; 10(5):384-403. PubMed ID: 9143858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.